A detailed history of Banque Cantonale Vaudoise transactions in Bio N Tech Se stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 323 shares of BNTX stock, worth $38,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares
323
Previous 2,474 86.94%
Holding current value
$38,288
Previous $199,000 80.9%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$78.36 - $124.66 $168,552 - $268,143
-2,151 Reduced 86.94%
323 $38,000
Q1 2024

Apr 10, 2024

SELL
$88.96 - $112.35 $5,337 - $6,741
-60 Reduced 2.37%
2,474 $229,000
Q3 2023

Nov 08, 2023

SELL
$98.5 - $125.08 $3,053 - $3,877
-31 Reduced 1.21%
2,534 $273,000
Q2 2023

Aug 09, 2023

SELL
$102.58 - $129.66 $23,490 - $29,692
-229 Reduced 8.2%
2,565 $277,000
Q1 2023

Apr 20, 2023

BUY
$122.57 - $153.67 $83,470 - $104,649
681 Added 32.23%
2,794 $347,000
Q4 2022

Feb 10, 2023

SELL
$118.43 - $186.05 $1.43 Million - $2.25 Million
-12,100 Reduced 85.13%
2,113 $320,000
Q3 2022

Oct 17, 2022

BUY
$127.65 - $183.11 $77,355 - $110,964
606 Added 4.45%
14,213 $1.92 Million
Q2 2022

Aug 02, 2022

BUY
$123.25 - $186.24 $850,671 - $1.29 Million
6,902 Added 102.94%
13,607 $2.03 Million
Q1 2022

May 09, 2022

SELL
$126.25 - $231.85 $699,046 - $1.28 Million
-5,537 Reduced 45.23%
6,705 $1.15 Million
Q4 2021

Feb 14, 2022

BUY
$216.64 - $362.52 $337,308 - $564,443
1,557 Added 14.57%
12,242 $3.15 Million
Q3 2021

Oct 29, 2021

SELL
$205.93 - $447.23 $75,164 - $163,238
-365 Reduced 3.3%
10,685 $2.92 Million
Q2 2021

Aug 11, 2021

BUY
$113.32 - $241.49 $1.13 Million - $2.41 Million
10,000 Added 952.38%
11,050 $2.47 Million
Q1 2021

May 11, 2021

BUY
$85.73 - $119.5 $90,016 - $125,475
1,050 New
1,050 $114,000
Q3 2020

Oct 30, 2020

SELL
$57.81 - $104.17 $21,389 - $38,542
-370 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$38.58 - $66.74 $14,274 - $24,693
370 New
370 $25,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.